SCOTUS Consideration Of Patents Could Provide Certainty To Drug Litigation

The Supreme Court plans to hold oral arguments in mid-October for a case that will determine whether the U.S. Court of Appeals for the Federal Circuit can review a patent claim without considering district court findings. A potential decision by the Supreme Court to overturn the appeals court's ruling would provide more certainty to district court decisions, which in turn could reduce litigation costs for drug companies, a patent lawyer said. The case centers on patents for the complex multiple...